Literature DB >> 15481634

Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy.

Rémy Sapin1, Michèle D'Herbomez, Jean-Louis Schlienger.   

Abstract

We measured free thyroxine in sera from 29 women in the ninth month of pregnancy. We used the reference method, equilibrium dialysis, and nine immunoassays. The bias between immunoassay and dialysis results was insignificant or modest. With all methods, the results were in the lower part of the non-pregnant female reference interval or below the lower limit of this interval: 10 results with the equilibrium dialysis assay and from 4 to 18 results with the nine immunoassays. Method-specific reference intervals should be determined during pregnancy to be in a position to quantify not only hypothyroidism but also hyperthyroidism and to adjust an appropriate T4 treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15481634

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  13 in total

1.  Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide.

Authors:  Offie P Soldin; Danielle Soldin; Marisol Sastoque
Journal:  Ther Drug Monit       Date:  2007-10       Impact factor: 3.681

2.  Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy.

Authors:  Natasa Kahric-Janicic; Steven J Soldin; Offie P Soldin; Threvia West; Jianghong Gu; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2007-04       Impact factor: 6.568

3.  Re-thinking the definitions of subclinical thyroid disease in pregnancy.

Authors:  R Negro
Journal:  J Endocrinol Invest       Date:  2011-02-07       Impact factor: 4.256

4.  Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.

Authors:  Alex Stagnaro-Green; Marcos Abalovich; Erik Alexander; Fereidoun Azizi; Jorge Mestman; Roberto Negro; Angelita Nixon; Elizabeth N Pearce; Offie P Soldin; Scott Sullivan; Wilmar Wiersinga
Journal:  Thyroid       Date:  2011-07-25       Impact factor: 6.568

5.  Therapeutic drug monitoring during pregnancy and lactation: thyroid function assessment in pregnancy-challenges and solutions.

Authors:  Offie P Soldin
Journal:  Ther Drug Monit       Date:  2010-06       Impact factor: 3.681

Review 6.  Thyroid function in pregnancy.

Authors:  Angela M Leung
Journal:  J Trace Elem Med Biol       Date:  2012-06-02       Impact factor: 3.849

Review 7.  Hypothyroxinemia and pregnancy.

Authors:  Roberto Negro; Offie P Soldin; Maria-Jesus Obregon; Alex Stagnaro-Green
Journal:  Endocr Pract       Date:  2011 May-Jun       Impact factor: 3.443

8.  High prevalence of thyroid dysfunction in pregnant women.

Authors:  M Altomare; S La Vignera; P Asero; D Recupero; R A Condorelli; P Scollo; A Gulisano; E Magro; D Tumino; S Tumino; E Vicari; V Leanza; R D'Agata; A E Calogero
Journal:  J Endocrinol Invest       Date:  2012-10-22       Impact factor: 4.256

Review 9.  Thyroid disorders in pregnancy.

Authors:  Alex Stagnaro-Green; Elizabeth Pearce
Journal:  Nat Rev Endocrinol       Date:  2012-09-25       Impact factor: 43.330

10.  Reference intervals of trimester-specific thyroid stimulating hormone and free thyroxine in Chinese women established by experimental and statistical methods.

Authors:  Lican Han; Wei Zheng; Yanhong Zhai; Xin Xie; Jingnan Zhang; Shaozu Zhang; Zhen Zhao; Zheng Cao
Journal:  J Clin Lab Anal       Date:  2017-11-04       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.